BSE filing, NSE: ASPIRA. Summary written from the filing by ALFA Finder's alert engine.
Aspira Pathlab & Diagnostics Ltd: key numbers
- Share price
- ₹133.80
- Market cap
- ₹137.7 Cr
- Revenue (annual)
- ₹24.98 Cr
- Net profit (annual)
- ₹0.05 Cr
- P/E (TTM)
- -304.3×Sector 52.3×
- Promoter holding
- 46.65%+0.07% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aspira Pathlab & Diagnostics Ltd
All →Aspira Pathlab & Diagnostics Other Announcement
Aspira Pathlab & Diagnostics Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.
Aspira Pathlab & Diagnostics Promoter Buying: ₹0.02 Cr
Promoter Jay Arvind Bhanushali acquired 1,424 equity shares of Aspira Pathlab & Diagnostics Ltd via market purchase. The transaction is valued at ₹0.02 Crore.
- Value
- ₹0.02 Cr
- Promoter stake change
- +0.01%
Aspira Pathlab & Diagnostics Promoter Buying
Promoter Jay Arvind Bhanushali acquired 1,424 shares of Aspira Pathlab & Diagnostics Ltd via the open market. This transaction increased the promoter's stake from 7.27% to 7.28%.
- Execution
- 17-09-2026 to 24-09-2026
- Promoter stake change
- +0.01%
Aspira Pathlab & Diagnostics Annual General Meeting
Aspira Pathlab & Diagnostics held its 53rd Annual General Meeting on September 25, 2026, where members deliberated on financial statements and various directorial appointments.
Aspira Pathlab & Diagnostics Promoter Buying: ₹0.01 Cr
Promoter Jay Arvind Bhanushali acquired 1,387 equity shares of Aspira Pathlab & Diagnostics Ltd through market purchase, increasing their stake from 7.25% to 7.27%.
- Value
- ₹0.01 Cr
- Promoter stake change
- +0.02%
Aspira Pathlab & Diagnostics Promoter Buying
Promoter Jay Arvind Bhanushali acquired 1,387 shares of Aspira Pathlab & Diagnostics Ltd via an open-market transaction, increasing his stake by 0.02%.
- Promoter stake change
- +0.02%
Other promoter reclassification announcements
All →L&T Finance Promoter Reclassification
L&T Finance received no-objection from BSE and NSE for reclassifying Nabha Power Ltd from Promoter Group to Public. No monetary value is associated with this regulatory reclassification.
Kkalpana Plastick Promoter Reclassification
Kkalpana Plastick reports promoters Bbigplas Poly and Sarla Surana reclassified to public after Ashish Begwani's open offer. Begwani, acquiring 40.12 lakh shares, becomes sole promoter.
Thirumalai Chemicals Promoter Reclassification
Thirumalai Chemicals received requests from two promoter group members, Narayan Santhanam and Deepa Ajay, to reclassify 100,000 shares (0.08%) as public. The board will consider the requests at its next meeting.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.
SBI Funds Management Promoter Reclassification
SBI Funds Management's shareholding filing seeks Regulation 31A reclassification of Indian Digital Payment Intelligence Corporation from promoter group to public. No monetary value is involved.
GSPL Transmission Promoter Reclassification
GSPL Transmission received a request from promoter GSEG to reclassify its 0.14% stake from Promoter to Public category under Regulation 31A. Reclassification awaits Board and exchange approval.